BriaCell Therapeutics
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | |||
EBITDA | -5,695 | -9,225 | -9,825 | -8,499 |
EBIT | -5,767 | -9,229 | -9,829 | -8,503 |
Net Income | -1,214 | 1,715 | -11,294 | 6,001 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,492 | -5,083 | -7,401 | -7,605 |
Cash | 862 | 935 | 6,244 | 13,645 |
Basic Shares | 16,454 | 16,674 | 15,981 | 16,674 |
Annual Financials
| Values in thousands | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -15 | -15 | -15 |
EBITDA | -22,365 | -11,502 | 3,705 |
EBIT | -22,381 | -11,518 | 3,689 |
Net Income | -20,302 | -11,549 | 3,689 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -23,744 | -12,484 | -7,747 |
Cash | 21,251 | 41,041 | 57,268 |
Basic Shares | 15,518 | 15,494 | 4,519 |
